ESC 365 - Incidence and predictors of heart failure events following cardiac surgery in patients with atrial fibrillation

Back

EHRA 2024 Premium Access

Incidence and predictors of heart failure events following cardiac surgery in patients with atrial fibrillation - insights from the LAAOS-III trial

Session: Atrial fibrillation: clinical

Topic: Heart Failure in Atrial Fibrillation

Speaker: Doctor L. Xing (Copenhagen, DK)

Event: EHRA 2024

Congress Presentation

About the speaker

Doctor Lucas Xing

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

0 follower

7 more presentations in this session

Is thyroid function testing necessary in all cases of new onset atrial fibrillation diagnosed in the emergency department? - a real-life study

Speaker: Doctor J. Hytting (Norrkoping, SE)

Effects of sodium glucose co-transporter-2 inhibitor on atrial tachyarrhythmia burden in patients with cardiovascular implantable electronic device

Speaker: Assistant Professor T. Nantsupawat (Chiang Mai, TH)

Comparison between Novel and Conventional Electrocardiographic Markers of Atrial Cardiomyopathy for identification of Persons at Risk for Ischemic Stroke

Speaker: Professor A. Jadidi (Lucerne, CH)

Incidence and outcome of periinterventional atrial fibrillation in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention

Speaker: Mr J. Jost (Vienna, AT)

Early rhythm control in patients with recently diagnosed atrial fibrillation: findings from the GLORIA-AF Registry Phase III

Speaker: Doctor B. Corica (Modena, IT)

Access the full session

Atrial fibrillation: clinical

Speakers: Doctor L. Xing, Doctor J. Hytting, Assistant Professor T. Nantsupawat, Professor A. Jadidi, Mr J. Jost...

Access

About the event

EHRA 2024

7 April - 9 April 2024

Sessions Presentations

Congress

Incidence and predictors of heart failure events following cardiac surgery in patients with atrial fibrillation - insights from the LAAOS-III trial

About the speaker

Doctor Lucas Xing

7 more presentations in this session

Is thyroid function testing necessary in all cases of new onset atrial fibrillation diagnosed in the emergency department? - a real-life study

Effects of sodium glucose co-transporter-2 inhibitor on atrial tachyarrhythmia burden in patients with cardiovascular implantable electronic device

Comparison between Novel and Conventional Electrocardiographic Markers of Atrial Cardiomyopathy for identification of Persons at Risk for Ischemic Stroke

Incidence and outcome of periinterventional atrial fibrillation in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention

Early rhythm control in patients with recently diagnosed atrial fibrillation: findings from the GLORIA-AF Registry Phase III

Access the full session

Atrial fibrillation: clinical

About the event

EHRA 2024

ESC 365 is supported by